Brain magnetic stimulation to reduce levodopa-induced dyskinesias in Parkinson's disease
Brain magnetic stimulation to reduce levodopa-induced dyskinesias in Parkinson's disease
批准号:
488794
负责人:
Di Paolo-Chenevert Thrèse
金额:
$20.06万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
未结题
起止时间:
2023-09-01 至 2025-09-01
中文摘要
帕金森氏症(PD)患者长期服用左旋多巴(黄金标准药物),通常会导致被称为运动障碍的异常不自主运动的发展,从而降低生活质量,而且难以治疗。Dyskin
英文摘要
The chronic exposure of people with Parkinson's disease (PD) to levodopa, the gold standard medication, mostly leads to the development of abnormal involuntary movements called dyskinesias that reduce the quality of life and are difficult to treat. Dyskin
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of therapeutic efficacy of deep brain stimulation in Parkinson's disease
-
批准号:321719
-
项目类别:Operating Grants
-
资助金额:$50.14万
-
财政年份:2015
-
负责人:Di Paolo-Chenevert Thrèse
-
依托单位:
Gonadal drugs for brain neuroprotection and neuromodulation
-
批准号:238660
-
项目类别:Operating Grants
-
资助金额:$47.58万
-
财政年份:2011
-
负责人:Di Paolo-Chenevert Thrèse
-
依托单位:
Bioavailable plasmalogen precursors in models of Parkinson's disease.
-
批准号:225237
-
项目类别:Operating Grants
-
资助金额:$22.95万
-
财政年份:2011
-
负责人:Di Paolo-Chenevert Thrèse
-
依托单位:
海外基金